Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream

JAAD Case Rep. 2016 Mar 4;2(2):114-6. doi: 10.1016/j.jdcr.2016.01.004. eCollection 2016 Mar.

Authors

Jonathan S Leventhal¹, Ian D Odell¹, Suguru Imaeda², Emanual Maverakis³, Brett A King²

Affiliations

¹ Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut.
² Yale University School of Medicine, Department of Dermatology, New Haven, Connecticut; Department of Veterans Affairs, West Haven, Connecticut.
³ University of California, Davis, California.

No abstract available

Keywords: IL-2, interleukin-2; imiquimod; immunotherapy; interleukin-2; medical dermatology; melanoma; oncology.

Publication types

Case Reports